Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Wheeler

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Diabetes Educator|January 1, 1987
Betakid--lessons learned while developing a microcomputer pediatric case simulationL A Wheeler, M P Golden, M L Wheeler, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|January 1, 1995
Effect of platelet-derived growth factor on rabbit corneal wound healingM E Stern, K M Waltz, R W Beurerman, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis of chiral and achiral pyranenamine derivatives. Potent agents with topical ocular antiallergic activityC Gluchowski, T E Bischoff, M E Garst, et al.
The European Respiratory Journal|April 10, 2009
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in femalesE D Austin, J D Cogan, J D West, et al.
Journal of Medicinal Chemistry|March 15, 1996
Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agentS A Munk, R K Lai, J E Burke, et al.
Journal of Medicinal Chemistry|January 3, 1997
Synthesis and evaluation of 2-(arylamino)imidazoles as alpha 2-adrenergic agonistsS A Munk, D A Harcourt, P N Arasasingham, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonistS A Munk, D Harcourt, G Ambrus, et al.
British Journal of Pharmacology|July 1, 2008
Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesY Liang, D F Woodward, V M Guzman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)D F Woodward, A H-P Krauss, J Chen, et al.
British Journal of Pharmacology|August 22, 2000
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compoundsD F Woodward, A H Krauss, J Chen, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Diabetes Educator|January 1, 1987
Betakid--lessons learned while developing a microcomputer pediatric case simulationL A Wheeler, M P Golden, M L Wheeler, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|January 1, 1995
Effect of platelet-derived growth factor on rabbit corneal wound healingM E Stern, K M Waltz, R W Beurerman, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis of chiral and achiral pyranenamine derivatives. Potent agents with topical ocular antiallergic activityC Gluchowski, T E Bischoff, M E Garst, et al.
The European Respiratory Journal|April 10, 2009
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in femalesE D Austin, J D Cogan, J D West, et al.
Journal of Medicinal Chemistry|March 15, 1996
Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agentS A Munk, R K Lai, J E Burke, et al.
Journal of Medicinal Chemistry|January 3, 1997
Synthesis and evaluation of 2-(arylamino)imidazoles as alpha 2-adrenergic agonistsS A Munk, D A Harcourt, P N Arasasingham, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonistS A Munk, D Harcourt, G Ambrus, et al.
British Journal of Pharmacology|July 1, 2008
Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesY Liang, D F Woodward, V M Guzman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)D F Woodward, A H-P Krauss, J Chen, et al.
British Journal of Pharmacology|August 22, 2000
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compoundsD F Woodward, A H Krauss, J Chen, et al.
Pageof 9